InvestSMART

Atomos Limited (ASX:AMS)

ALERT: Price-sensitive ASX Announcement for AMS
Current share price for AMS : $0.010 -0.003 (-23.08%)+
Announcement
Release
31 Aug 2026 6:43PM
Price at Release
$0.013
Full Release
download
Summary
Atomos Limited’s Appendix 4E Preliminary Unaudited Final Report for the Australian financial year ended 30 June 2026 reports a turnaround in performance, with revenue rising 22.5% to $40.0 million, EBITDA improving to a positive $3.7 million from a loss of $11.8 million, and net profit after tax attributable to members of $0.9 million compared with a $14.6 million loss in FY25, driven by stronger contribution margins, lower fixed costs following prior restructuring, and benefits from inventory provision releases and improved product cost outcomes; the report also highlights the acquisition of Flanders Scientific, Inc. on 24 April 2026 for total consideration of about $2.5 million, which added $1.8 million in revenue for the post-acquisition period, expanded Atomos’ monitor and post-production product range, and resulted in recognition of acquired intangible assets and related deferred tax balances, while the Group ended the year with net liabilities of $2.6 million, higher borrowings, negative net tangible assets of 0.5 cents per share, no dividend, continuing operating cash outflows, and an expected unmodified audit opinion with emphasis on material uncertainty related to going concern.
Key Points
  • FY26 revenue increased 22.5% to $39.997 million from $32.656 million in FY25.
  • Atomos returned to profitability with net profit after tax of $872,000 versus a loss of $14.581 million in FY25.
  • EBITDA improved to $3.665 million from a negative $11.833 million in the prior year.
  • Contribution margin rose to $14.867 million or 37.2% of revenue, up from 16.8%, reflecting improved product cost outcomes and provision releases.
  • Total fixed costs fell 22.5% to $12.5 million after restructuring benefits, including lower employee, marketing, and professional costs.
  • Finance costs increased to $2.599 million due to a higher average level of borrowings.
  • No dividends were paid or declared for FY26.
  • Net tangible assets per share were negative 0.5 cents at 30 June 2026.
  • Atomos acquired Flanders Scientific, Inc. on 24 April 2026 through a wholly owned subsidiary for total consideration of approximately $2.482 million.
  • Flanders Scientific contributed $1.8 million of revenue and a small after-tax loss from acquisition to 30 June 2026.
  • The acquisition added identifiable intangible assets including a supply agreement, trademark, and customer relationships.
  • Capitalised product development costs resumed from 1 January 2026, with $1.355 million capitalised in FY26.
  • Net cash used in operating activities was $4.959 million, while financing activities provided $9.932 million.
  • Borrowings increased to $20.881 million and the Group ended the year with net liabilities of $2.632 million.
  • The report states the audit is near completion and an unmodified opinion is expected, with attention drawn to material uncertainty related to going concern.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should refer to the full announcement here for further information.